Product Information
 



Healing Rates:



Data from a multicenter, randomized, double-blind, parallel-group, 6-month trial comparing NEXIUM 20 mg
with lansoprazole 15 mg administered once daily in patients with endoscopically confirmed healed EE with
NEXIUM 40 mg.
†Log-rank test at 6 months.

Adapted from Lauritsen, et al.9

  • NEXIUM 20 mg and lansoprazole 15 mg are the FDA-approved doses for maintenance of healing of EE
  • Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with omeprazole, of which NEXIUM is an enantiomer5

The most frequently reported adverse events with NEXIUM are headache, diarrhea, and abdominal pain. Symptomatic response to therapy does not preclude the presence of gastric malignancy.
As with all PPIs, patients treated concomitantly with warfarin may need to be monitored for increases in INR and prothrombin time.

NEXIUM should be used only for the conditions, dosages, and durations specified in the Prescribing Information. Before prescribing NEXIUM, please see accompanying full Prescribing Information

References: 1. Data on file, DA-NEX-26. 2. Data on file, DA-NEX-33. 3. Data on file, DA-NEX-34. 4. Data on file, DA-NEX-31. 5. Prescribing Information for NEXIUM. 6. Castell DO, Kahrilas PJ, Richter JE, et al. Am J Gastroenterol. 2002;97:575-583. 7. Richter JE, Kahrilas PJ, Johanson J, et al. Am J Gastroenterol. 2001;96:656-665. 8. Kahrilas PJ, Falk GW, Johnson DA, et al. Aliment Pharmacol Ther. 2000;14:1249-1258. 9. Lauritsen K, Devière J, Bigard M-A, et al. Aliment Pharmacol Ther. 2003;17:333- 341. 10. Johnson DA, Benjamin SB, Vakil NB, et al. Am J Gastroenterol. 2001;96:27-34. 11. Vakil NB, Shaker R, Johnson DA, et al. Aliment Pharmacol Ther. 2001;15:927-935. 12. Data on file, DA-NEX-18. 13. Data on file, DA-NEX-32.

 



Home | Product Information | Patient Education | News & Studies
Digital Library | Web Resources | NEXIUM Science
NEXIUM Prescribing Information | Feedback | Contact Us


Privacy Statement Legal Information
This product information is intended for US Health Care professionals only.

NEXIUM and the color purple as applied to the capsule are registered trademarks of the AstraZeneca group of companies.
222923 09/04 Copyright ©2008 AstraZeneca LP. All rights reserved.
US Corporate Site